JPMorgan Chase & Co’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.5K | Buy |
|
|||||
|
2025
Q1 | $27K | Buy |
|
|||||
|
2024
Q4 | $39.6K | Buy |
|
|||||
|
2024
Q3 | $38K | Buy |
|
|||||
|
2024
Q2 | $35.5K | Sell |
|
|||||
|
2024
Q1 | $350K | Buy |
|
|||||
|
2023
Q4 | $7.5K | Sell |
|
|||||
|
2023
Q3 | $3.4K | Buy |
|
|||||
|
2023
Q2 | $18 | Hold |
|
|||||
|
2023
Q1 | $0 | Sell |
|
|||||
|
2022
Q4 | $0 | Hold |
|
|||||
|
2022
Q3 | $0 | Hold |
|
|||||
|
2022
Q2 | $0 | Sell |
|
|||||
|
2022
Q1 | $2K | Buy |
|
|||||
|
2021
Q4 | $0 | Sell |
|
|||||
|
2021
Q3 | $128K | Sell |
|
|||||
|
2021
Q2 | $368K | Sell |
|
|||||
|
2021
Q1 | $640K | Buy |
|
|||||
|
2020
Q4 | $529K | Buy |
|
|||||
|
2020
Q3 | $227K | Buy |
|
|||||
|
2020
Q2 | $137K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $102K | Sell |
|
|||||
|
2019
Q3 | $789K | Sell |
|
|||||
|
2019
Q2 | $1.7M | Sell |
|
|||||
|
2019
Q1 | $1.85M | Buy |
|
|||||
|
2018
Q4 | $1.12M | Buy |
|
|||||
|
2018
Q3 | $714K | Buy |
|
|||||
|
2018
Q2 | $36K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $39K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $128K | Buy |
|
|||||
|
2013
Q2 | $92K | Buy |
|